Abdulkader Puranwala
Stock Analyst at ICICI Securities
(3.32)
# 2,403
Out of 4,581 analysts
40
Total ratings
65.4%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,065 → ₹6,850 | ₹5,831 | +17.48% | 4 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,840 → ₹8,820 | ₹8,930 | -1.23% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Maintained: Sell | ₹1,570 → ₹1,640 | ₹2,232 | -26.54% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,115 → ₹2,275 | ₹2,502 | -9.07% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Maintained: Buy | ₹655.00 → ₹600.00 | ₹663.30 | -9.54% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Maintained: Buy | ₹1,800 → ₹1,965 | ₹2,005 | -2.00% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Maintained: Sell | ₹890.00 → ₹810.00 | ₹938.85 | -13.72% | 2 | Aug 14, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Maintained: Buy | ₹600.00 | ₹594.40 | +0.94% | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | ₹950.40 | -10.04% | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | ₹798.55 | -21.11% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹5,400 | ₹7,853 | -31.24% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,110 → ₹1,950 | ₹2,426 | -19.61% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹900.00 | ₹804.55 | +11.86% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | ₹1,591 | -18.27% | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹590.00 | ₹670.00 | -11.94% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,900 → ₹1,500 | ₹1,903 | -21.19% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,000 | ₹1,372 | n/a | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹910.00 → ₹486.62 | ₹591.90 | n/a | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,200 | ₹1,144 | n/a | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | ₹428.70 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | ₹2,618 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,000 | ₹1,117 | n/a | 1 | Feb 6, 2025 |
Alkem Laboratories Limited
May 28, 2026
Maintained: Buy
Price Target: ₹6,065 → ₹6,850
Current: ₹5,831
Upside: +17.48%
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Maintained: Buy
Price Target: ₹8,840 → ₹8,820
Current: ₹8,930
Upside: -1.23%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Maintained: Sell
Price Target: ₹1,570 → ₹1,640
Current: ₹2,232
Upside: -26.54%
Gland Pharma Limited
Jan 29, 2026
Maintained: Buy
Price Target: ₹2,115 → ₹2,275
Current: ₹2,502
Upside: -9.07%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Maintained: Buy
Price Target: ₹655.00 → ₹600.00
Current: ₹663.30
Upside: -9.54%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Maintained: Buy
Price Target: ₹1,800 → ₹1,965
Current: ₹2,005
Upside: -2.00%
NATCO Pharma Limited
Aug 14, 2025
Maintained: Sell
Price Target: ₹890.00 → ₹810.00
Current: ₹938.85
Upside: -13.72%
Metropolis Healthcare Limited
Aug 11, 2025
Maintained: Buy
Price Target: ₹600.00
Current: ₹594.40
Upside: +0.94%
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: ₹950.40
Upside: -10.04%
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: ₹798.55
Upside: -21.11%
Aug 7, 2025
Maintained: Sell
Price Target: ₹5,400
Current: ₹7,853
Upside: -31.24%
Aug 7, 2025
Maintained: Hold
Price Target: ₹2,110 → ₹1,950
Current: ₹2,426
Upside: -19.61%
Aug 6, 2025
Maintained: Hold
Price Target: ₹900.00
Current: ₹804.55
Upside: +11.86%
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: ₹1,591
Upside: -18.27%
Aug 5, 2025
Maintained: Hold
Price Target: ₹590.00
Current: ₹670.00
Upside: -11.94%
Aug 1, 2025
Maintained: Hold
Price Target: ₹2,900 → ₹1,500
Current: ₹1,903
Upside: -21.19%
Jul 29, 2025
Maintained: Sell
Price Target: ₹1,000
Current: ₹1,372
Upside: n/a
Jul 25, 2025
Maintained: Buy
Price Target: ₹910.00 → ₹486.62
Current: ₹591.90
Upside: n/a
Jul 24, 2025
Maintained: Hold
Price Target: ₹1,200
Current: ₹1,144
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: ₹428.70
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: ₹2,618
Upside: n/a
Feb 6, 2025
Maintained: Hold
Price Target: ₹1,000
Current: ₹1,117
Upside: n/a